Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone and Ibritumomab Intravenous
Determining the interaction of Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: citric acid / glucono-delta-lactone / magnesium carbonate topical
Brand name: Renacidin
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-Ibritumomab Tiuxetan
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-Ibrutinib
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-Ibrutinib Capsules
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-Ibrutinib Tablets
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-Ibu
- Citric Acid, Magnesium Carbonate, and Glucono-Delta-Lactone-IBU Tablets
- Ibritumomab Intravenous-Citric acid, magnesium oxide, and sodium picosulfate
- Ibritumomab Intravenous-Citric acid, potassium citrate, and sodium citrate
- Ibritumomab Intravenous-Citric Acid, Sodium Citrate, and Potassium Citrate
- Ibritumomab Intravenous-Citroma
- Ibritumomab Intravenous-Citrucel
- Ibritumomab Intravenous-Citrucel (Methylcellulose Powder and Powder Packets)